Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
ADI, in collaboration with academics from the London School of Economics, published a commentary in Nature Reviews Neurology urging governments to include dementia in NCD policies and frameworks. This paper reveals striking data, including dementia becoming the 3rd leading cause of death globally by 2040 and among the top 10 causes of death in 166 countries.
On 10 December, ADI launched its inaugural End of Year Forecast, focusing on ‘Translating the Alzheimer's Treatment Revolution into Real World Solutions’. This event sought to highlight the new era for Alzheimer’s treatments and cut through the often confusing and cryptic information that is available to the general public. ADI is pleased to share the slide featured in this event. Make sure to scroll down the page to see all 127 Alzheimer’s treatments and their place in the pipeline.
The annual event brings together basic scientists, clinical researchers, early career investigators, clinicians and the care research community to discuss the latest developments and innovation in Alzheimer’s and dementia research.
Lecanemab represents the first antibody treatment for Alzheimer’s disease to have received traditional approval from the Food and Drug Administration in the US.
Her Royal Highness Princess Muna Al Hussein is the fourth global Ambassador of ADI, joining Queen Silvia of Sweden, Queen Sofia of Spain and the Luis Guillermo Solís Rivera, former President of Costa Rica.
With only a fifth of WHO Member States meeting their commitments to the Global Action Plan on dementia, urgent action is needed to address the escalating global dementia crisis.
ADI member Dementia Australia has developed an app to help support brain health and encourage more timely dementia diagnoses.
As ADI prepares to attend the G7 summit in Hiroshima, Japan, DY Suharya writes about the journey of making dementia a priority at the G7 summit.
The month of March has marked significant progress in the development and implementation of National Dementia Plans (NDPs), with the #WhatsYourPlan campaign leading to the launch of plans in Uruguay and Armenia, bringing the total number of WHO Member States with NDPs to 41.
Silverado Senior Living is the first care home provider to receive ADI Accreditation since the launch of the accreditation programme in 2021.